Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences submits postal ballot notice

>>

Zydus Lifesciences gets NMPA’s approval for Venlafaxine ER capsules

>>

Zydus Lifesciences gets USFDA’s approval for Olaparib Tablets

>>

Zydus Lifesciences’ consolidated net profit surges 38% in Q2

>>

Zydus Lifesciences - Quaterly Results

>>

Zydus Lifesciences gets Orphan Drug Designation from USFDA for Desidustat

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences gets EIR report with Nill observations from USFDA

>>

Zydus Lifesciences gets USFDA’s tentative approval for Budesonide capsules

<< < 7 8 9 ...168 > >>